Growth Investment Hermes Pharma is expanding its manufacturing capacity with multi-million euro plant investments to meet rising demand for user-friendly oral dosage forms. Opportunity for supply chain partnerships, line expansion, and co-development of scalable formats.

Niche Expertise Specialization in effervescent, chewable, lozenges, instant drinks and orally disintegrating granules positions Hermes Pharma as a go-to contract manufacturer for consumer-friendly dosage forms. Potential to target OTC brands and nutraceuticals seeking similar formats.

Regulatory Support Comprehensive capabilities from formulation through regulatory support suggest value in end-to-end development collaborations, fast-tracking product launches and ensuring compliant market access for partners.

Global Collaboration Longstanding partner orientation with healthcare companies worldwide and a sister OTC brand portfolio indicate strong cross-sell potential for outsourcing manufacturing, packaging, and regulatory services to expand partner ecosystems.

Digital & Compliance Adoption of modern tech stack including Azure, DocuSign, and data/document management tools signals readiness for digital collaboration, e-signatures, and secure MES/quality workflows to streamline joint programs.